Personalized Diabetes Therapy Part 1-Functional Phenotyping as a Conceptual Basis for Individualized Treatment

Area of Science:

• Endocrinology
• Metabolic Diseases
• Personalized Medicine

Background:

• Current type 2 diabetes diagnosis relies on clinical markers (HbA1c, glucose, lipids, BMI, blood pressure), offering limited insight into underlying pathophysiology.
• Pathophysiological disorders like insulin resistance, beta-cell dysfunction, and chronic inflammation are key to understanding disease progression.
• A deeper understanding of these disorders is crucial for developing effective, personalized therapeutic interventions.

Purpose of the Study:

• To present a novel method for individual phenotyping in type 2 diabetes.
• To describe the pathophysiological background and diagnostic approach for this phenotyping method.
• To lay the groundwork for personalized diabetes therapy based on individual patient phenotypes.

Main Methods:

• Development of a personalized phenotyping method based on extensive clinical trial experience.
• Focus on understanding underlying pathophysiological disorders beyond standard diagnostic biomarkers.
• Description of the diagnostic approach for phenotyping in Part 1 of this series.

Main Results:

• The presented method aims to classify patients based on distinct pathophysiological profiles.
• This phenotyping approach moves beyond traditional symptom-based diagnosis.
• It facilitates a more targeted selection of personalized therapeutic strategies.

Conclusions:

• Traditional type 2 diabetes diagnosis needs enhancement with pathophysiological insights.
• Individualized phenotyping offers a pathway to more precise and potentially successful diabetes management.
• Further prospective validation studies are required to confirm the clinical utility of this phenotype-based framework.